Biological active bullets, systems, and methods

• US 9,945,650 B2
• Filed: 06/27/2016
• Issued: 04/17/2018
• Est. Priority Date: 05/02/2012
• Status: Active Grant

• Current Assignee: Darren Rubin
• Original Assignee: Darren Rubin
• Inventors: Rubin, Darren
• Primary Examiner(s): HAYES, BRET C
• Application Number:
  US15/193,801
• Publication Number:
  US 20160298947A1
• Time in Patent Office: 659 Days
• Field of Search: 102511, 102512, 102513, 102458, 102364, 102365
• CPC Class Codes: F42B 12/54 by implantation, e.g. hypodermic projectiles
• CPC Class Codes: F42B 12/72 characterised by the material heat treatment for explosive shells C21D9/16

Abstract

A hemostatic bullet projectile is for discharge from a firearm and for use as a weapon. The ammunition is a bullet in a cartridge. The bullet projectile includes, and is distinguished by, the use of at least one potentially biological active substance delivered to a bullet wound of a target and serving as a hemostatic agent to promote blood clotting and/or control hemorrhage in the bullet would to stabilize the target until surgery can be performed. Methods are included to promote blood clotting and/or control hemorrhage in at least one bullet wound by delivery of a hemostatic agent by the bullet projectile causing the wound as well as minimizing the risk of embolism from the hemostatic bullet projectile.

Claims

1. A method of promoting blood clotting and or controlling hemorrhage in at least one bullet wound;

said method including the steps of aiming a firearm at a human target and discharging from said firearm a bullet projectile associated with at least one hemostatic agent, and making said at least one hemostatic agent immediately available to interact with blood in said at least one bullet wound of said human target, while minimizing the risk of causing an embolism in said target.